HitGen announced drug discovery collaboration with Scripps Research Institute and Calibr
On Apr. 24, 2017, HitGen announced a drug discovery collaboration with the Scripps Research Institute and Calibr. This…
Biotechnology | Disease | Infectious Disease | Influenza | Non-Profit Research | Therapeutics | Vaccine
CDC updated guidelines for use of non-pharmaceutical measures to help prevent spread of pandemic influenza
On Apr. 21, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published updated guidelines for use…
Some 300 million people suffer from depression worldwide
On Mar. 31, 2017, more than 300 million people are now living with depression, which is the leading…
Bezos family donated $35 million to Fred Hutch
On Mar. 30, 2017, the Fred Hutchinson Cancer Research Center announced that the Bezos family had donated $35…
Genentech drug Ocrevus (ocrelizumab) was approved
On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…
University of Alberta researchers announced they had discovered the protein Rab32 in the brains of MS patients.
On Mar. 25, 2017, University of Alberta researchers announced they had discovered the protein Rab32 in the brains…
the Siteman Cancer Network Center was launched
On Mar. 3, 2017, Siteman Cancer Center launched the Siteman Cancer Network to improve the health of individuals…
Cleveland Clinic opened new cancer Center
On Feb. 16, 2017, the new Cleveland Clinic Taussig Cancer Center began welcoming patients. The 377,000-square-foot facility, estimated…
Jeffrey and Patricia Cole donated $2.25 million to Cleveland Clinic Florida Tomsich Health and Medical Center
On Jan. 23, 2017, Jeffrey and Patricia Cole donated $2.25 million to Cleveland Clinic Florida Tomsich Health and…
PharmAthene and Altimmune announced merger to create immunotherapeutics company targeting infectious diseases
On Jan. 19, 2017, PharmAthene and Altimmune, a privately-held immunotherapeutics company targeting infectious diseases, announced an agreement for…
Abbott completed aquisition of St Jude Medical Valued at $25 billion
On Jan. 4, 2017, Abbott announced it had completed the acquisition of St. Jude Medical, establishing the company…
Abbott completed acquisition of St Jude Medical for $25 billion
On Jan. 4, 2017, Abbott announced it had completed the acquisition of St. Jude Medical for $25 billion….
First drug approved by the FDA for treatment of canine lymphoma
On Jan. 3, 2017, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) announced the conditional…
BioXcel therapeutics was founded
In 2017, BioXcel Therapeutics was founded in New Haven, Connecticut as a clinical-stage biopharmaceutical company that utilizes novel…
SpringWorks Therapeutics was founded
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
The Vanderbilt Microbiome Initiative was founded
In 2017, the Vanderbilt Microbiome Initiative (VMI) at Vanderbilt University was established bringing together an unprecedented group of…
Genomic sequencing illuminated Shigella outbreaks in California
On Dec. 23, 2016, researchers at University of California (UC) Davis and California Department of Public Health announced…
Biotechnology | Disease | NIH | Therapeutics | Vaccine
Medigen Vaccines Biologics teamed with U.S. CDC to develop VLP vaccine for Dengue disease
On Dec. 14, 2016, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
Bristol-Myers Squibb announced closure of Seattle’s ZymoGenetics operation
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
Biotechnology | Diagnostics | Disease | Genomics | Medicine | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome Project
On Dec. 3, 2016, Celgene, Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences announced the…
Artificial Intelligence | Biotechnology | Disease | Genomics | Infectious Disease | Medicine | Non-Profit Research | Therapeutics
Washington University invested $25 million in imaging sciences
On Nov. 18, 2016, Washington University in St. Louis launched a bold, $25 million initiative over the next…
The U.S. Surgeon General issued landmark Report on Alcohol, Drugs, and Health
On Nov. 17, 2016, the U.S. Surgeon General Dr. Vivek Murthy issued a landmark Report on Alcohol, Drugs,…
Biotechnology | CRISPR | Disease | Genomics | NIH | Non-Profit Research | Therapeutics
The National Institutes of Health issued guidelines for DNA splicing
On Nov. 15, 2016, the National Institutes of Health (NIH) issued guidelines for DNA splicing. The guidelines set…
Fred Hutch opened first-of-its kind Bezos Family Immunotherapy Clinic
On Nov. 1, 2016, the Fred Hutchinson Cancer Research Center announced the opening of the Bezos Family Immunotherapy…
Biotechnology | Chemical | Disease | FDA | Oncology | Therapeutics
Genentech drug Tecentriq (atezolizumab) was approved
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
UO launched $1 billion Phil and Penny Knight Campus for Accelerating Scientific Impact
On Oct. 18, 2016, the University of Oregon (UO) announced the $1 billion Phil and Penny Knight Campus…
$10 million gift created Bursky Center for Human Immunology and Immunotherapy
On Sept. 26, 2016, Washington University School of Medicine in St. Louis announced it had received a $10…
New prostate cancer therapy investigated at Vanderbilt University Medical Center
On Sept. 22, 2016, Vanderbilt University Medical Center became the world’s first site to treat a prostate cancer…
Thermo Fisher Scientific completed its acquisition of FEI Company
On Sept. 19, 2016, Thermo Fisher announced it had completed its acquisition of FEI Company for a total…
Bayer and Monsanto announced merger
On Sept. 14, 2016, Bayer and Monsanto announced a merger agreement whereby Bayer acquired Monsanto for USD $128…